UNSPSC 51162326: Acetaminophen/pseudoephedrine/triprolidine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF) which falls under VA Drug Class RE599. This VA Drug Class (RE599) classifies this compound as belonging to the group COLD REMEDIES, OTHER.

The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate.

UNSPSC 51162326 Acetaminophen/pseudoephedrine/triprolidine, a Commodity code, shows minimal recent state and local procurement activity directly aligned with the code's nominal scope. The two recent opportunities tagged under this code involve parenteral pharmaceutical products and naloxone distribution—neither of which matches the specific combination drug therapy this code nominally describes. The Washington State Department of Corrections RFQ RFQQK13020 solicits parenteral nutrition solutions, intravenous solutions, and controlled substances for incarcerated individuals, with delivery requirements ranging from 8 to 24 hours depending on product type. The Seminole County, Florida IFB 60459723LAS seeks naloxone units and drug deactivation systems for community health initiatives. These opportunities reflect broader pharmaceutical and medical-supply procurement by state corrections departments and county health authorities, but neither involves acetaminophen/pseudoephedrine/triprolidine formulations.

State and local activity under this code is concentrated among corrections and public-health agencies. The Washington State Department of Corrections anticipates awarding up to three contractors per region across eight facilities spanning West, Central, and East regions of Washington state, with an initial contract term running November 26, 2026 through June 30, 2030 and fixed pricing for the first two years. Seminole County's naloxone procurement calls for 1,900 units and 800 deactivation systems annually with quarterly deliveries, an initial two-year term, and a one-year renewal option. The geographic spread reflects Washington state and Florida activity, though the code's sparse recent-opportunity footprint and the mismatch between the code's defined scope and the actual work being solicited suggest limited current market traction for this specific pharmaceutical combination in state and local procurement.